Ocugen Inc (($OCGN)) announced an update on their ongoing clinical study. Study Overview: Ocugen Inc. is conducting a Phase 1 study titled ‘A ...
Kyowa Kirin Co (($KYKOF)) announced an update on their ongoing clinical study. Kyowa Kirin Co. is conducting a Phase 2 clinical study titled ‘A ...
Feb. 6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two treatments per ...
A single-number metric from a handheld device outperformed dozens of other measurements for the prediction of ...
David Eichenbaum, MD, FASRS, recalls an early-career case managing bilateral diabetic macular edema with frequent ...
A biosimilar demonstrated comparable efficacy and safety to aflibercept in treating diabetic macular edema. The vascular endothelial growth factor inhibitor was one of two aflibercept biosimilars ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Brolucizumab ...
Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...
GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, ...
Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened its label as a treatment for diabetic macular edema (DME), which is the ...
Joseph M. Coney, MD, FACS, reviews best practices for improving adherence to treatment among patients with diabetic macular edema through comprehensive education on the disease and available therapies ...
These injections can restore your eyesight and ward off vision loss. And they aren’t nearly as stressful as you might think. No one really looks forward to getting a shot — and when you’re living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results